News

HHS Proposes restrictions on the QALY: CEVR weighs in

October 12, 2023 Read Article

The impact of the CVS-Aetna merger on Aetna enrollees’ access to specialty drugs

October 2, 2023 Read Article

CEVR congratulates Dan Ollendorf on his new role at ICER

September 27, 2023 Read Article

First look at US commercial health payers’ coverage of Amjevita™ shows Humira® remaining on top—at least for now

September 12, 2023 Read Article

New CEVR publication: Turning CMS into a Health Technology Assessment Organization

August 25, 2023 Read Article

How US commercial health plans are covering semaglutide (Wegovy®) for obesity management

August 17, 2023 Read Article

Variation in payer coverage of mavacamten (Camzyos) for hypertrophic cardiomyopathy: one year post approval

August 9, 2023 Read Article

CEVR Welcomes 2023 CEA Registry Summer Fellows

June 12, 2023 Read Article

5th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner

April 25, 2023 Read Article

New CEVR publication: Cost-effectiveness thresholds used by study authors, 1990-2021

April 18, 2023 Read Article